Home » Newsletters » BioWorld Science

BioWorld Science

May 20, 2014

View Archived Issues

New cost-effective, easy-to-perform, point-of-care tests for the diagnosis of malaria

Takeda presents phase III results for TAK-438

NeoStem signs licensing agreement with Cellular Biomedicine for DC-TC

Otsuka Pharmaceutical profiles pipeline progress of fourth quarter of fiscal 2013

Gene transfer trial for spinal muscular atrophy type 1 begins patient recruitment

AstraZeneca to collaborate with UK Medical Research Council's Laboratory of Molecular Biology

Lipocine reports phase I data for pre-term birth product candidate LPCN-1107

Hemispherx Biopharma enters collaboration to test Alferon N Injection in Tamiflu-resistant strains

Adalimumab receives FDA orphan drug status for uveitis

MK-2206/ridaforolimus combination active in advanced breast cancer

NCL-1 impairs prostate cancer growth in vivo

Tetra Discovery Partners patents new PDE4 inhibitors

Merck & Co. synthesizes novel sodium channel blockers

Selinexor receives orphan drug designation for acute myeloid leukemia

HHS presents adoptive cell transfer-based cancer immunotherapy

Afamelanotide gains FDA and EMA orphan status for benign familial pemphigus

FDA confirms no association between Fluzone and febrile seizures

FDA grants breakthrough therapy designation to elotuzumab

Shire to submit an NDA to the FDA for lifitegrast

Ventrus Biosciences and Assembly Pharmaceuticals in merger agreement

Clovis Oncology's CO-1686 awarded breakthrough therapy designation

Hanmi initiates phase I trial of dual glucagon and GLP-1 receptor agonist

European conditional MAAs withdrawn for vintafolide and companion imaging agents

AstraZeneca rejects Pfizer's final proposal

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 10, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...